Tudorza Pressair: Medgend

Tudorza Pressair FDA Approved Drugs

TUDORZA PRESSAIR [Aclidinium Bromide^{C₂₆H₃₀NO₄S₂Br}]

0.4mg/inh (inhalation powder, metered)

Astrazeneca Pharms^{Jul 23, 2012}

Treatment of chronic obstructive pulmonary disease (copd) or chronic bronchitis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.